Buon’s agammaglobulinemia is due to?
**Core Concept**
Buon's agammaglobulinemia, also known as X-linked agammaglobulinemia (XLA), is a genetic disorder characterized by the inability to produce mature B lymphocytes and, consequently, immunoglobulins. This leads to recurrent infections and impaired immune function. The underlying pathophysiology involves a defect in the B cell development process.
**Why the Correct Answer is Right**
The correct answer is related to the mutation in the BTK gene, which encodes for Bruton's tyrosine kinase. This enzyme is crucial for the signaling pathway that promotes the development and maturation of B cells. In XLA, mutations in the BTK gene lead to a deficiency in BTK activity, resulting in the failure of B cells to mature and produce immunoglobulins. This, in turn, impairs the immune system's ability to fight off infections.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect as it does not accurately describe the underlying cause of Buon's agammaglobulinemia. While it may be a related condition, it is not the primary cause of XLA.
* **Option B:** This option is incorrect as it is not directly related to the pathophysiology of Buon's agammaglobulinemia. The correct answer involves a specific genetic mutation, not a broader category of immune disorders.
* **Option D:** This option is incorrect as it does not accurately describe the genetic basis of Buon's agammaglobulinemia. While there may be other genetic disorders that affect the immune system, the correct answer specifically involves a mutation in the BTK gene.
**Clinical Pearl / High-Yield Fact**
XLA is an X-linked recessive disorder, meaning it predominantly affects males. Female carriers of the mutated BTK gene may exhibit mild symptoms or remain asymptomatic due to X-chromosome inactivation.
**Correct Answer:** C. Mutation in the BTK gene.